AssetMark’s BioLife Solutions BLFS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$350 Sell
9
-19
-68% -$642 ﹤0.01% 3504
2026
Q2
$791 Hold
28
– – ﹤0.01% 3192
2026
Q1
$534 Hold
28
– – ﹤0.01% 3174
2025
Q4
$677 Buy
+28
New +$733 ﹤0.01% 3038

Other funds holding BLFS

AssetMark's BLFS Position: Q3 2026 in Review

AssetMark reduced its BioLife Solutions (BLFS) stake by 68% in Q3 2026, selling an estimated $642 and leaving 9 shares worth $350. The position accounts for ﹤0.01% of the portfolio, ranked #3504.

AssetMark first reported a position in BLFS in Q4 2025 and has held it in 4 quarters since. The position peaked at $791 in Q2 2026. 176 funds tracked by Wall St. Rank hold BLFS as of Q3 2026.

  • AssetMark held 9 shares of BioLife Solutions worth $350 as of Q3 2026.
  • AssetMark sold 19 BioLife Solutions shares in Q3 2026, an estimated $642.
  • BioLife Solutions made up ﹤0.01% of AssetMark's portfolio in Q3 2026, its #3504 holding.
  • AssetMark first reported a position in BioLife Solutions in Q4 2025 and has held it in 4 quarters since.
  • AssetMark's BioLife Solutions position peaked at $791 in Q2 2026.
  • 176 funds tracked by Wall St. Rank held BioLife Solutions as of Q3 2026.

Based on AssetMark's 13F filing for Q3 2026, filed 21 Oct 2026.